Skip to main content
logo
Quince Therapeutics, Inc. (IRLA)
NASDAQ: IRLA · Real-Time Price · USD
28.00
-3.73 (-11.76%)
Oct 12, 2026, 12:37 PM EDT - Market open

Quince Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
28187824523377
Market Cap Growth
-126.70%82.80%95.46%-93.89%-53.99%
Enterprise Value
-8817850-38-71264
Last Close Price
31.73670.00374.00210.00127.482524.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.30-5.222.730.530.233.18
P/TBV Ratio
---11.890.243.18

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.520.490.160.010.01
Net Debt / Equity Ratio
-1.07-0.02-0.86-0.72-0.89-0.89
Net Debt / EBITDA Ratio
1.91-0.010.722.521.801.17
Net Debt / FCF Ratio
2.47-0.020.813.322.031.67
Quick Ratio
14.230.495.737.9529.717.59
Current Ratio
14.520.536.058.0930.557.85
Return on Equity (ROE)
-153.84%--98.63%-33.81%-47.14%-61.85%
Return on Assets (ROA)
-31.51%-30.31%-16.01%-11.33%-26.40%-34.99%
Return on Capital Employed (ROCE)
-52.60%-100.30%-33.70%-15.60%-49.70%-75.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-286.56%-45.02%-69.06%-69.73%-224.32%-23.86%
FCF Yield
-145.64%-22.40%-39.09%-40.99%-191.80%-16.74%
Buyback Yield / Dilution
-704.22%-15.80%-16.18%-11.17%-12.71%-1.86%